ARROW IPN033564Recalls & reported problems
Teleflex Incorporated · PICC Two-Lumen Peripherally Inserted Central Catheter Set with Blue FlexTip(R) Catheter · Class 2 · Implant
All models of ARROW (1494)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00801902095848), received between Jul 26, 2023 and Jan 21, 2025 — classified as 1 injury, 6 malfunctions.
The most frequently reported specific device problem is “Obstruction of Flow” (4 reports).
4 other recalls cover devices cleared under the same FDA submission (K042126); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Obstruction of Flow4
- Device Dislodged or Dislocated1
- Material Puncture/Hole1
- Material Separation1
- Material Twisted/Bent1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
- Insufficient Information2
- Vascular Dissection1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 21, 2025Material Puncture/Hole; Device Dislodged or Dislocated; Material Puncture/Hole; Device Dislodged or Dislocated
IT WAS REPORTED "A CATHETER IS LOCATED IN THE PATIENT, MOISTURE IS EVIDENCED, IT IS DISPLACED, AND A PERFORATION IS EVIDENCED, SO IT IS DECIDED TO WITHDRAW". THE PATIENT HAD BEEN WITH THE CATHETER FOR 4 DAYS (FROM THE ICU), SO IT WAS NOT POST-INSERTION. THE CATHETER PERFORATION IS EVIDENT 5 CENTIMETRES FROM THE INSERTION SITE. THE PATIENT HAD NO HARM OR INJURY.
Patient problems: Insufficient Information
MAUDE report 21196000 ↗MalfunctionDec 6, 2024Obstruction of Flow; Obstruction of Flow
IT WAS REPORTED THAT: "THE PROCEDURE OF PASSING A PERIPHERAL INSERTION CENTRAL CATHETER - PICC TO THE PATIENT IS PERFORMED, THEY OBSERVE THAT THERE IS NO BLOOD RETURN, THEY EVALUATE THE CATHETER POSITIONING , WITHOUT FINDING ANY EVENTUALITY, WHEN THERE IS NO RETURN, THEY REMOVE IT AND TRY WITH ANOTHER CATHETER WITH WHICH THEY OBTAIN IMMEDIATE RETURN. THE EXTRACTED CATHETER IS TESTED FOR PERMEABILITY, FINDING AN UNUSUAL RESISTANCE, IT IS NECESSARY TO MAKE A LOT OF FORCE TO THE EMBOLUS AND THE AMOUNT THAT PASSES IS MINIMAL. THIS EVENT IMPLIED A DOUBLE PUNCTURE OF THE PATIENT. THERE WAS NO REPORTED PATIENT HARM."
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20863020 ↗MalfunctionDec 5, 2024Obstruction of Flow; Obstruction of Flow
IT WAS REPORTED THAT: "THE PROCEDURE OF PASSING A PERIPHERAL INSERTION CENTRAL CATHETER - PICC TO THE PATIENT IS PERFORMED, WHEN PERFORMING THE PROCEDURE, THEY OBSERVE THAT THERE IS NO BLOOD RETURN, THEY EVALUATE THE CATHETER POSITIONING, WITHOUT FINDING ANY EVENTUALITY, WHEN NO RETURN IS OBTAINED, THEY REMOVE IT AND TRY WITH ANOTHER CATHETER WITH WHICH THEY OBTAIN IMMEDIATE RETURN, THE EXTRACTED CATHETER IS TESTED FOR PERMEABILITY, FINDING AN UNUSUAL RESISTANCE, IT IS NECESSARY TO MAKE MUCH FORCE TO THE EMBOLUS AND THE AMOUNT THAT PASSES IS MINIMAL. THIS EVENT IMPLIED THE DOUBLE PUNCTURE OF THE PATIENT. THE PATIENT WAS REPORTED AS FINE POST THE PROCEDURE WITH NO HARM REPORTED." ASSOCIATED COMPLAINTS 9680794-2024-01205, AND 9680794-2024-01200.
Patient problems: Insufficient Information
MAUDE report 20853757 ↗MalfunctionDec 5, 2024Obstruction of Flow; Obstruction of Flow
IT WAS REPORTED THAT: "THE PROCEDURE OF PASSING A PERIPHERAL INSERTION CENTRAL CATHETER - PICC. TO THE PATIENT IS PERFORMED, WHEN PERFORMING THE PROCEDURE, THEY OBSERVE THAT THERE IS NO BLOOD RETURN, THEY EVALUATE THE CATHETER POSITIONING, WITHOUT FINDING ANY EVENTUALITY, WHEN NO RETURN IS OBTAINED, THEY REMOVE IT AND TRY WITH ANOTHER CATHETER WITH WHICH THEY OBTAIN IMMEDIATE RETURN, THE EXTRACTED CATHETER IS TESTED FOR PERMEABILITY, FINDING AN UNUSUAL RESISTANCE, IT IS NECESSARY TO MAKE MUCH FORCE TO THE EMBOLUS AND THE AMOUNT THAT PASSES IS MINIMAL. THIS EVENT IMPLIED THE DOUBLE PUNCTURE OF THE PATIENT. THE PATIENT WAS REPORTED AS FINE POST THE PROCEDURE WITH NO HARM REPORTED." ASSOCIATED COMPLAINTS 9680794-2024-01203 AND 9680794-2024-01200.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20853481 ↗MalfunctionDec 5, 2024Obstruction of Flow; Obstruction of Flow
IT WAS REPORTED THAT: "THE PROCEDURE OF PASSING A PERIPHERAL INSERTION CENTRAL CATHETER - PICC TO THE PATIENT IS PERFORMED, WHEN PERFORMING THE PROCEDURE, THEY OBSERVE THAT THERE IS NO BLOOD RETURN, THEY EVALUATE THE CATHETER POSITIONING, WITHOUT FINDING ANY EVENTUALITY, WHEN NO RETURN IS OBTAINED, THEY REMOVE IT AND TRY WITH ANOTHER CATHETER WITH WHICH THEY OBTAIN IMMEDIATE RETURN, THE EXTRACTED CATHETER IS TESTED FOR PERMEABILITY, FINDING AN UNUSUAL RESISTANCE, IT IS NECESSARY TO MAKE MUCH FORCE TO THE EMBOLUS AND THE AMOUNT THAT PASSES IS MINIMAL. THIS EVENT IMPLIED THE DOUBLE PUNCTURE OF THE PATIENT. THE PATIENT WAS REPORTED AS FINE POST THE PROCEDURE WITH NO HARM REPORTED." ASSOCIATED COMPLAINTS: 9680794-2024-01205, 9680794-2024-01203.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20853123 ↗InjuryNov 14, 2024Material Twisted/Bent; Material Twisted/Bent
IT WAS REPORTED "PCC BILUMEN CATHETER IS PASSED TO GUARANTEE MEDICAL TREATMENT OF 44 DAYS IN THE LEFT UPPER LIMB WITHOUT COMPLICATION, IT IS EVIDENCED BY X- RAYS THAT IT HAS BEEN ANGLED WHY IT IS DECIDED TO ACCOMMODATE THE CONTROL X-RAY CONTINUES TO SHOW THE ACODE IT IS DECIDED TO WITHDRAW EVIDENCING THAT IT COMES OUT ELBOWED AND CANNOT BE REMOVED THROUGH THE INSERTION POINT IT IS INDICATED TO THE DOCTOR WHO DETERMINES EVALUATION BY PERIPHERAL VASCULAR CX TO REMOVE IT." ADDITIONAL INFORMATION REPORTS THERE WAS "DAMAGE TO THE INTIMAL LAYER OF THE VEIN IN THE CATHETER PATH." THE PATIENT'S CURRENT CONDITION IS REPORTED AS "FINE".
Patient problems: Vascular Dissection
MAUDE report 20684633 ↗MalfunctionJul 26, 2023Material Separation; Material Separation
IT WAS REPORTED WHEN ADMINISTERING MEDICATION THROUGH THE BILUMEN PICC, ONE OF THE PORTS WAS FOUND COVERED WITH ADHESIVE TAPE AND THE DISTAL CONNECTOR OF THE PICC BROKEN. NO PATIENT HARM WAS REPORTED. THE PATIENT'S CONDITION IS REPORTED AS FINE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17396379 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K042126. One submission often covers many models, so check the product and lot details in each record.
- Z-2378-2026 · Apr 21, 2026 · Open, ClassifiedDescription/REF: PI PICC: 3: 6FR x 55CM w CHG/ DLX-35563-HPKC; AGBA PICC: 2L 5.5 FR X 45 CM/ASK-44552-ABKB; AGBA PICC/DELTA KIT: 5.5 FR X 55 CM/ASK-45552-MHBV; AGBA PICC: 1L 4.5FR
- Z-2825-2015 · Aug 27, 2015 · TerminatedArrow Kits with Medtronic Covidien 0.9% Sodium Chloride Flush Syringes
- Z-2462-2015 · Jul 30, 2015 · TerminatedPICC Kits with Peel-Away Sheath Component; catheter, intravascular, therapeutic, ultrasound Product Usage: catheter, intravascular, therapeutic, ultrasound
- Z-1503-2009 · Feb 11, 2009 · TerminatedArrow Peripherally Inserted Central Catheter
Other Catheter,intravascular,therapeutic,long-term greater than 30 days devices
- Groshong NXT ClearVue Catheter 7617405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 deaths1,708 reports
- Groshong NXT ClearVue Catheter 7655405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 deaths1,536 reports
- PowerPICC Catheter 3174118Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall402 reports
- L-Cath™ S/L PICC S/L 26GA (1.9F) x 30cmArgon Medical Devices, Inc. · Catheter,Intravascular,Therapeutic,Long-Term Greater Than 30 Days2 recalls245 reports
- PowerPICC SOLO2 Catheter 1194108DBard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 recalls216 reports
- Broviac 0600520Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall265 reports
- Groshong® Catheter 7717405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days279 reports
- PowerPICC® Catheters 1174108DBard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall222 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page